Still, considering the ongoing uncertainty, investors might want to buy stocks that have limited exposure to tariffs and global trade tensions. Here are three great options to consider. The Nasdaq Composite (^IXIC 1.61%) technology index was down by as much as 24% from its all-time high in April, placing it in a bear market. The sell-off was triggered by President Donald Trump's "Liberation Day" tariffs, which sparked fears of a sharp economic slowdown. But several countries are negotiating new trade deals ...

The three major benchmarks soared on Monday as the U.S. announced an initial import tariff agreement with China. This was a game-changing moment for investors as concerns about President Donald Trump's tariff plan had weighed on sentiment for weeks. Investors were particularly worried about an escalating trade war with China that could wreak havoc on the economy. But that worst-case scenario seems to be drifting away. This week, the U.S. agreed to set tariffs at 30% on China, a level light-years away from t ...

Company Overview - eToro has priced its IPO at $52 per share, raising nearly $310 million and valuing the company at approximately $4.2 billion [1] - Founded in 2007 by brothers Yoni and Ronen Assia along with David Ring, eToro competes with platforms like Robinhood and generates revenue through trading fees and non-trading activities [5] Financial Performance - eToro's net income surged almost thirteenfold to $192.4 million in the last year, up from $15.3 million the previous year [6] - Revenue from cryptoassets more than tripled to over $12 million in 2024, with one-quarter of its net trading contribution coming from crypto, an increase from 10% the prior year [6] IPO Context - The IPO market is showing signs of recovery, with eToro's Nasdaq debut under the ticker symbol ETOR being a potential indicator of market readiness for risk [4] - eToro previously attempted to go public in 2022 through a SPAC merger, which was scrapped due to a downturn in equity markets [7] Investor Interest - BlackRock has expressed interest in purchasing $100 million in shares at the IPO price, with the company planning to sell 5 million shares in the offering, alongside existing investors selling another 5 million [8]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading activities [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].

Core Viewpoint - Invesco is an independent investment management firm focused on enhancing the investment experience for individuals, aiming to help them achieve more in life [1] Group 1 - Invesco emphasizes the importance of understanding investment objectives, risks, charges, and expenses before making investment decisions [1] - The firm provides educational information but does not constitute a recommendation for any specific investment strategy [1] - Invesco advises investors to consult their own legal or tax professionals due to the complexity and variability of federal and state tax laws [1] Group 2 - The opinions expressed by Invesco's authors are based on current market conditions and are subject to change without notice [1] - Invesco's investment advisory services are provided by affiliated investment advisers, and they do not sell securities [1] - Invesco Unit Investment Trusts are distributed by Invesco Capital Markets, Inc., and other broker-dealers [1]

Core Viewpoint - The Stock Exchange of Thailand (SET) and Nasdaq have announced an expanded strategic technology partnership aimed at modernizing Thailand's capital markets, focusing on enhancing market resilience, integrity, and aligning with global standards through the use of Nasdaq's AI capabilities [1][2]. Group 1: Partnership Objectives - The collaboration will promote the adoption of Nasdaq's risk and surveillance platforms within SET's member community to drive consistent infrastructure across the market ecosystem [2]. - The initiative aims to enhance systemwide efficiency, transparency, and risk management, benefiting from common market infrastructure and Nasdaq's ongoing investments in modernization [2][3]. Group 2: Market Impact - The partnership is expected to strengthen liquidity, transparency, and integrity in Thailand's capital markets, fostering trust and investor confidence [3]. - By adopting advanced risk and surveillance solutions, SET aims to improve its ability to detect market abuse and monitor trading activities, reinforcing Thailand's leadership in ASEAN's capital markets [3][4]. Group 3: Nasdaq's Global Reach - Nasdaq's technology is utilized by 97% of globally systematically important banks, half of the world's top 25 stock exchanges, and over 3,800 clients in the financial services industry [3]. - The partnership reflects Nasdaq's commitment to advancing industry-wide modernization through deep strategic relationships and mission-critical solutions [4]. Group 4: Future Vision - Together, SET and Nasdaq are laying the foundation for a robust, future-ready capital market ecosystem, enhancing Thailand's position as a regional innovation leader and financial hub [5].

Core Viewpoint - Hepion Pharmaceuticals has transitioned from developing treatments for chronic liver diseases to focusing on diagnostic tests, while facing delisting from Nasdaq due to non-compliance with listing standards [1][2]. Company Overview - Hepion Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that was previously developing treatments for non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) [1]. - The company's primary asset, Rencofilstat, is a potent inhibitor of cyclophilins, which has shown efficacy in reducing liver fibrosis and HCC tumor burden in experimental models [3]. Recent Developments - On May 9, 2025, the company received a notice from Nasdaq indicating that its shares would be delisted due to failure to maintain a minimum bid price of $1.00 per share and being classified as a public shell [1]. - Following the suspension of trading on Nasdaq, the company's shares are expected to be quoted on the OTC Markets Group under the existing symbol "HEPA" [2]. - Hepion announced a license agreement with New Day Diagnostics LLC on May 9, 2025, to in-license diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), H. pylori, and HCC, with some tests already having CE marks for sale in Europe [5]. Clinical Trials - In April 2024, Hepion decided to wind down its ASCEND-NASH clinical trial, which was a Phase 2b study aimed at evaluating the safety and efficacy of Rencofilstat over 12 months, with a target enrollment of 336 subjects [4]. - Enrollment in the trial was paused in April 2023 after 151 subjects were randomized, and approximately 80 subjects have completed their Day 365 visits [4].

Core Viewpoint - American Bitcoin Corp. has entered into a definitive merger agreement with Gryphon Digital Mining, Inc. to become a publicly traded entity focused on Bitcoin accumulation at scale [1] Company Overview - American Bitcoin is a majority-owned subsidiary of Hut 8, dedicated to industrial-scale Bitcoin mining and strategic Bitcoin reserve development [4] - The company aims to create a low-cost Bitcoin accumulation platform, leveraging Hut 8's mining operations and Eric Trump's expertise in capital markets [4] Transaction Details - The merger will be a stock-for-stock transaction, with the combined company expected to trade on Nasdaq under the ticker symbol "ABTC" [1][7] - The anticipated closing timeline for the transaction is targeted for Q3 2025 [7] - Post-transaction, existing stockholders of American Bitcoin are expected to own approximately 98% of the combined company [7] Management and Governance - The combined company will be led by the management and board of directors of American Bitcoin, including key figures such as Eric Trump and Asher Genoot [1][7]

Core Viewpoint - Tech stocks are experiencing a rally, presenting investment opportunities in major companies despite previous downturns [1][2][3] Group 1: Amazon - Amazon Web Services (AWS) generated $29.3 billion last quarter, reflecting a 17% year-over-year growth, although slower than competitors [5] - The company plans over $100 billion in capital expenditures by 2025, primarily to increase AWS capacity and invest in custom AI silicon solutions [6] - Shipping expenses grew only 3% year over year while paid units increased by 8%, indicating improved logistics efficiency [8] - Amazon's enterprise value is less than 3 times the 2025 sales estimates, approximately 10% below its long-term average, suggesting a favorable valuation for investors [10] Group 2: Lam Research - Lam Research is a leading manufacturer of semiconductor fabrication equipment, with 43% of its revenue from memory chip manufacturers [11][12] - The company reported a 24% revenue growth last quarter and anticipates further growth in Q2, despite tariff uncertainties [13] - Lam is expected to increase its market share in wafer fabrication equipment, outpacing the semiconductor industry's growth [14] - The stock trades at 19 times forward earnings estimates, with management projecting double-digit earnings growth over the next four years [15] Group 3: Meta Platforms - Meta Platforms increased its capital spending plans for the year to between $64 billion and $72 billion, focusing on AI investments [16] - The company reported a 16% revenue growth last quarter, driven by strong engagement and rising ad prices [17] - AI tools are expected to enhance marketing capabilities and customer service, potentially generating significant revenue from Meta's messaging apps [18] - Meta has consistently produced over $10 billion in free cash flow for eight consecutive quarters, supporting ongoing investments in technology [19] - The stock trades at 23 times forward earnings estimates, with potential for double-digit earnings growth, indicating it is undervalued [20]

Core Points - Shopify Inc. will be added to the Nasdaq-100 Index and the Nasdaq-100 Equal Weighted™ Index on May 19, 2025, replacing MongoDB, Inc. [1] - MongoDB, Inc. will be removed from multiple Nasdaq indices, including the Nasdaq-100 Tech Sector™ Index and others, on the same date [2] Company Information - Nasdaq is a leading global technology company that provides services to corporate clients, investment managers, banks, brokers, and exchange operators, focusing on improving liquidity, transparency, and integrity in the global economy [4]